Eric L. Keller
Director, CHIEF EXECUTIVE OFFICER · 1 filing · Latest: Oct 13, 2026
Retension Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RTSN | Eric L. Keller | Director, CHIEF EXECUTIVE OFFICER | Oct 13, 2026 | Purchase | $12.00 | 20,800 | $249.6K | 423,377 |